In vivo 31P nuclear magnetic resonance spectroscopy of rat 9l gliosarcoma treated with BCNU: Dose response of spectral changes

R. Grant Steen, Rafael J. Tamargo, Henry Brem, Jerry D. Glickson, Janna P. Wehrle

Research output: Contribution to journalArticlepeer-review

Abstract

The 9L gliosarcoma, grown subcutaneously in juvenile Fischer 344 rats, was studied by in vivo 31P NMR spectroscopy following treatment with 1,3‐bis(2‐chloroethyl)‐ 1‐nitrosourea. Dose‐dependent increases in the proportion of high‐energy phosphates were observed for doses between 10 and 36 mg/kg (from 80% of the LD10 to greater than the LD50). These doses reduced clonogenic cell survival in a dose‐dependent fashion by as much as 3 log orders and resulted in up to 16 days of growth delay (to pretreatment tumor volume). Increases in high‐energy phosphates (relative to Pi) in the tumor were greater at higher doses despite the higher levels of clonogenic cell killing and the substantial host Systemic toxicity.

Original languageEnglish (US)
Pages (from-to)258-266
Number of pages9
JournalMagnetic resonance in medicine
Volume11
Issue number2
DOIs
StatePublished - Aug 1989

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'In vivo <sup>31</sup>P nuclear magnetic resonance spectroscopy of rat 9l gliosarcoma treated with BCNU: Dose response of spectral changes'. Together they form a unique fingerprint.

Cite this